Cargando…

Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field

OBJECTIVES: To develop a modified Vesical Imaging Reporting and Data System (VI-RADS) without dynamic contrast-enhanced imaging (DCEI), termed “non-contrast-enhanced VI-RADS (NCE-VI-RADS)”, and to assess the additive impact of denoising deep learning reconstruction (dDLR) on NCE-VI-RADS. METHODS: Fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Masanaka, Taguchi, Satoru, Machida, Haruhiko, Tambo, Mitsuhiro, Takeshita, Yuhei, Kariyasu, Toshiya, Fukushima, Keita, Shimizu, Yuta, Okegawa, Takatsugu, Fukuhara, Hiroshi, Yokoyama, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668777/
https://www.ncbi.nlm.nih.gov/pubmed/35554648
http://dx.doi.org/10.1007/s00330-022-08813-4
_version_ 1784831986778505216
author Watanabe, Masanaka
Taguchi, Satoru
Machida, Haruhiko
Tambo, Mitsuhiro
Takeshita, Yuhei
Kariyasu, Toshiya
Fukushima, Keita
Shimizu, Yuta
Okegawa, Takatsugu
Fukuhara, Hiroshi
Yokoyama, Kenichi
author_facet Watanabe, Masanaka
Taguchi, Satoru
Machida, Haruhiko
Tambo, Mitsuhiro
Takeshita, Yuhei
Kariyasu, Toshiya
Fukushima, Keita
Shimizu, Yuta
Okegawa, Takatsugu
Fukuhara, Hiroshi
Yokoyama, Kenichi
author_sort Watanabe, Masanaka
collection PubMed
description OBJECTIVES: To develop a modified Vesical Imaging Reporting and Data System (VI-RADS) without dynamic contrast-enhanced imaging (DCEI), termed “non-contrast-enhanced VI-RADS (NCE-VI-RADS)”, and to assess the additive impact of denoising deep learning reconstruction (dDLR) on NCE-VI-RADS. METHODS: From January 2019 through December 2020, 163 participants who underwent high-gradient 3-T MRI of the bladder were prospectively enrolled. In total, 108 participants with pathologically confirmed bladder cancer by transurethral resection were analyzed. Tumors were evaluated based on VI-RADS (scores 1–5) by two readers independently: an experienced radiologist (reader 1) and a senior radiology resident (reader 2). Conventional VI-RADS assessment included all three imaging types (T2-weighted imaging [T2WI], diffusion-weighted imaging [DWI], and dynamic contrast-enhanced imaging [DCEI]). Also evaluated were NCE-VI-RADS comprising only non-contrast-enhanced imaging types (T2WI and DWI), and “NCE-VI-RADS with dDLR” comprising T2WI processed with dDLR and DWI. All systems were assessed using receiver-operating characteristic curve analysis and simple and/or weighted κ statistics. RESULTS: Muscle invasion was identified in 23/108 participants (21%). Area under the curve (AUC) values for diagnosing muscle invasion were as follows: conventional VI-RADS, 0.94 and 0.91; NCE-VI-RADS, 0.93 and 0.91; and “NCE-VI-RADS with dDLR”, 0.96 and 0.93, for readers 1 and 2, respectively. Simple κ statistics indicated substantial agreement for NCE-VI-RADS and almost perfect agreement for conventional VI-RADS and “NCE-VI-RADS with dDLR” between the two readers. CONCLUSION: NCE-VI-RADS achieved predictive accuracy for muscle invasion comparable to that of conventional VI-RADS. Additional use of dDLR improved the diagnostic accuracy of NCE-VI-RADS. KEY POINTS: • Non-contrast-enhanced Vesical Imaging Reporting and Data System (NCE-VI-RADS) was developed to avoid risk related to gadolinium-based contrast agent administration. • NCE-VI-RADS had predictive accuracy for muscle invasion comparable to that of conventional VI-RADS. • The additional use of denoising deep learning reconstruction (dDLR) might further improve the diagnostic accuracy of NCE-VI-RADS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-08813-4.
format Online
Article
Text
id pubmed-9668777
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96687772022-11-18 Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field Watanabe, Masanaka Taguchi, Satoru Machida, Haruhiko Tambo, Mitsuhiro Takeshita, Yuhei Kariyasu, Toshiya Fukushima, Keita Shimizu, Yuta Okegawa, Takatsugu Fukuhara, Hiroshi Yokoyama, Kenichi Eur Radiol Urogenital OBJECTIVES: To develop a modified Vesical Imaging Reporting and Data System (VI-RADS) without dynamic contrast-enhanced imaging (DCEI), termed “non-contrast-enhanced VI-RADS (NCE-VI-RADS)”, and to assess the additive impact of denoising deep learning reconstruction (dDLR) on NCE-VI-RADS. METHODS: From January 2019 through December 2020, 163 participants who underwent high-gradient 3-T MRI of the bladder were prospectively enrolled. In total, 108 participants with pathologically confirmed bladder cancer by transurethral resection were analyzed. Tumors were evaluated based on VI-RADS (scores 1–5) by two readers independently: an experienced radiologist (reader 1) and a senior radiology resident (reader 2). Conventional VI-RADS assessment included all three imaging types (T2-weighted imaging [T2WI], diffusion-weighted imaging [DWI], and dynamic contrast-enhanced imaging [DCEI]). Also evaluated were NCE-VI-RADS comprising only non-contrast-enhanced imaging types (T2WI and DWI), and “NCE-VI-RADS with dDLR” comprising T2WI processed with dDLR and DWI. All systems were assessed using receiver-operating characteristic curve analysis and simple and/or weighted κ statistics. RESULTS: Muscle invasion was identified in 23/108 participants (21%). Area under the curve (AUC) values for diagnosing muscle invasion were as follows: conventional VI-RADS, 0.94 and 0.91; NCE-VI-RADS, 0.93 and 0.91; and “NCE-VI-RADS with dDLR”, 0.96 and 0.93, for readers 1 and 2, respectively. Simple κ statistics indicated substantial agreement for NCE-VI-RADS and almost perfect agreement for conventional VI-RADS and “NCE-VI-RADS with dDLR” between the two readers. CONCLUSION: NCE-VI-RADS achieved predictive accuracy for muscle invasion comparable to that of conventional VI-RADS. Additional use of dDLR improved the diagnostic accuracy of NCE-VI-RADS. KEY POINTS: • Non-contrast-enhanced Vesical Imaging Reporting and Data System (NCE-VI-RADS) was developed to avoid risk related to gadolinium-based contrast agent administration. • NCE-VI-RADS had predictive accuracy for muscle invasion comparable to that of conventional VI-RADS. • The additional use of denoising deep learning reconstruction (dDLR) might further improve the diagnostic accuracy of NCE-VI-RADS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-08813-4. Springer Berlin Heidelberg 2022-05-12 2022 /pmc/articles/PMC9668777/ /pubmed/35554648 http://dx.doi.org/10.1007/s00330-022-08813-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Urogenital
Watanabe, Masanaka
Taguchi, Satoru
Machida, Haruhiko
Tambo, Mitsuhiro
Takeshita, Yuhei
Kariyasu, Toshiya
Fukushima, Keita
Shimizu, Yuta
Okegawa, Takatsugu
Fukuhara, Hiroshi
Yokoyama, Kenichi
Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field
title Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field
title_full Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field
title_fullStr Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field
title_full_unstemmed Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field
title_short Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field
title_sort clinical validity of non-contrast-enhanced vi-rads: prospective study using 3-t mri with high-gradient magnetic field
topic Urogenital
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668777/
https://www.ncbi.nlm.nih.gov/pubmed/35554648
http://dx.doi.org/10.1007/s00330-022-08813-4
work_keys_str_mv AT watanabemasanaka clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT taguchisatoru clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT machidaharuhiko clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT tambomitsuhiro clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT takeshitayuhei clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT kariyasutoshiya clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT fukushimakeita clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT shimizuyuta clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT okegawatakatsugu clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT fukuharahiroshi clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield
AT yokoyamakenichi clinicalvalidityofnoncontrastenhancedviradsprospectivestudyusing3tmriwithhighgradientmagneticfield